Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.07%106.1B | 4.77%407.83B | 4.69%100.42B | 6.39%101.95B | 12.71%389.27B | 95.92B | 95.83B | 345.37B |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 5.97%77.2B | 2.55%320.89B | 2.83%79.46B | -1.63%72.85B | -1.47%312.91B | 77.27B | 74.06B | 317.59B |
| Operating profit | -0.68%28.9B | 13.86%86.94B | 12.43%20.96B | 33.69%29.1B | 174.89%76.36B | 18.65B | 21.77B | 27.78B |
| Net non-operating interest income (expenses) | 1.20%-2.97B | 3.83%-11.87B | 3.48%-2.97B | 3.41%-3B | -20.73%-12.34B | -3.08B | -3.11B | -10.22B |
| Non-operating interest expense | -1.20%2.97B | -3.83%11.87B | -3.28%2.97B | -3.41%3B | 20.73%12.34B | --3.08B | --3.11B | --10.22B |
| Net investment income | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||
| Income from associates and other participating interests | -155.56%-5M | -64.00%99M | 12.00%28M | -71.88%9M | -44.78%275M | 25M | 32M | 498M |
| Special income (charges) | 10,333.87%6.47B | -2,203.60%-2.34B | -166.67%-94M | -72.81%62M | -86.45%111M | 141M | 228M | 819M |
| Less:Other special charges | -10,333.87%-6.47B | 315.67%1.09B | 166.67%94M | 72.81%-62M | 38.46%-504M | ---141M | ---228M | ---819M |
| Less:Write off | ---- | 217.56%1.25B | ---- | ---- | --393M | ---- | ---- | --0 |
| Other non-operating income (expenses) | -80.29%27M | 31.16%1.49B | -62.50%105M | 128.33%137M | 4.32%1.14B | 280M | 60M | 1.09B |
| Income before tax | 23.26%32.42B | 13.41%74.33B | 12.62%18.04B | 38.60%26.3B | 228.33%65.54B | 16.01B | 18.98B | 19.96B |
| Income tax | 22.67%10.11B | 6.77%20.58B | 10.77%5.4B | 40.36%8.24B | 346.88%19.28B | 4.87B | 5.87B | -7.81B |
| Net income | 23.53%22.32B | 16.18%53.75B | 13.41%12.64B | 37.83%18.06B | 66.58%46.26B | 11.14B | 13.11B | 27.77B |
| Net income continuous operations | 23.53%22.32B | 16.18%53.75B | 13.43%12.64B | 37.82%18.06B | 66.58%46.26B | --11.14B | --13.11B | --27.77B |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 23.53%22.32B | 16.18%53.75B | 13.41%12.64B | 37.83%18.06B | 66.58%46.26B | 11.14B | 13.11B | 27.77B |
| Preferred stock dividends | ||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 23.53%22.32B | 16.18%53.75B | 13.41%12.64B | 37.83%18.06B | 66.58%46.26B | 11.14B | 13.11B | 27.77B |
| Gross dividend payment | ||||||||
| Basic earnings per share | 23.54%38.41 | 16.18%92.51 | 13.41%21.747 | 37.83%31.0912 | 66.58%79.6248 | 19.1756 | 22.5577 | 47.7986 |
| Diluted earnings per share | 23.54%38.41 | 16.18%92.51 | 13.41%21.747 | 37.83%31.0912 | 66.58%79.6248 | 19.1756 | 22.5577 | 47.7986 |
| Dividend per share | 0 | 40 | ||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |